[HTML][HTML] Aberrant protein glycosylation: Implications on diagnosis and Immunotherapy

R Bangarh, C Khatana, S Kaur, A Sharma… - Biotechnology …, 2023 - Elsevier
Glycosylation-mediated post-translational modification is critical for regulating many
fundamental processes like cell division, differentiation, immune response, and cell-to-cell …

Nanoscale materials-based hybrid frameworks modified electrochemical biosensors for early cancer diagnostics: An overview of current trends and challenges

S Agrahari, RK Gautam, AK Singh, I Tiwari - Microchemical Journal, 2022 - Elsevier
Early detection and diagnostics are essential for the cure of cancer which has high mortality
rate globally. In recent decades, various methods such as mammography, computed …

Surface plasmon resonance: A promising approach for label-free early cancer diagnosis

A Gade, A Sharma, N Srivastava, SJS Flora - Clinica Chimica Acta, 2022 - Elsevier
Cancer is the second leading cause of death worldwide after cardiovascular disease. The
major cause of high mortality is delayed detection. Therefore, detection at an early stage …

Artificial intelligence and lung cancer: impact on improving patient outcomes

Z Gandhi, P Gurram, B Amgai, SP Lekkala… - Cancers, 2023 - mdpi.com
Simple Summary In this comprehensive review, we aimed to summarize the advances made
by artificial intelligence in the field of lung cancer screening, diagnosis, and management …

Identification of biomarkers for the early detection of non-small cell lung cancer: a systematic review and meta-analysis

E Mohamed, DJ García Martínez, MS Hosseini… - …, 2024 - academic.oup.com
Lung cancer (LC) causes few symptoms in the earliest stages, leading to one of the highest
mortality rates among cancers. Low-dose computerised tomography (LDCT) is used to …

A Highly Sensitive and Specific Non‐Invasive Test through Genome‐Wide 5‐Hydroxymethylation Mapping for Early Detection of Lung Cancer

Y Ren, Z Zhang, Y She, Y He, D Li, Y Shi, C He… - Small …, 2024 - Wiley Online Library
Low‐dose computed tomography screening can increase the detection for non‐small‐cell
lung cancer (NSCLC). To improve the diagnostic accuracy of early‐stage NSCLC detection …

Smart nanomaterials for cancer diagnosis and treatment

R Singh, A Sharma, J Saji, A Umapathi, S Kumar… - Nano …, 2022 - Springer
Innovations in nanomedicine has guided the improved outcomes for cancer diagnosis and
therapy. However, frequent use of nanomaterials remains challenging due to specific …

Recent advances in multifunctional dendrimer-based nanoprobes for breast cancer theranostics

P Kesharwani, R Chadar, R Shukla… - Journal of …, 2022 - Taylor & Francis
Breast cancer (BC) undoubtedly is one of the most common type of cancers amongst
women, which causes about 5 million deaths annually. The treatments and diagnostic …

Are there new biomarkers in tissue and liquid biopsies for the early detection of non-small cell lung cancer?

F Calabrese, F Lunardi, F Pezzuto, F Fortarezza… - Journal of clinical …, 2019 - mdpi.com
Lung cancer is one of the most lethal malignancies worldwide, mainly due to its late
diagnoses. The detection of molecular markers on samples provided from routine …

Emerging role of phytochemicals in targeting predictive, prognostic, and diagnostic biomarkers of lung cancer

J Singh, S Luqman, A Meena - Food and Chemical Toxicology, 2020 - Elsevier
Lung-cancer is the foremost cause of cancer in humans worldwide, of which 80–85% cases
are composed of non-small cell lung carcinoma. All treatment decisions depend on the …